Lyell Immunopharma, Inc. LYEL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-06-17
Chart by TradingView
1/9
Piotroski F — financial health
-13.93
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $36,000 | $61,000 | $130,000 | $84.7M | $10.7M |
| Operating income | -$269.4M | -$358.8M | -$247.0M | -$187.1M | -$214.8M |
| Net income | -$274.4M | -$343.0M | -$234.6M | -$183.1M | -$250.2M |
| Operating cash flow | -$150.0M | -$162.4M | -$163.7M | -$169.6M | -$126.2M |
| Free cash flow | -$150.8M | -$162.9M | -$166.4M | -$193.8M | -$191.8M |
| Total assets | $340.1M | $490.9M | $750.0M | $937.6M | $1.1B |
| Total liabilities | $91.8M | $108.0M | $95.1M | $104.3M | $197.6M |
| Shareholders' equity | $248.2M | $382.8M | $655.0M | $833.3M | $929.8M |
| Ratios | |||||
| Operating margin | -748344.4% | -588123.0% | -190006.2% | -220.9% | -2016.7% |
| Net margin | -762355.6% | -562285.2% | -180486.2% | -216.2% | -2349.5% |
| FCF margin | -418900.0% | -266980.3% | -127984.6% | -228.9% | -1800.5% |
| Return on assets | -80.7% | -69.9% | -31.3% | -19.5% | -22.2% |
| Return on equity | -110.6% | -89.6% | -35.8% | -22.0% | -26.9% |
| Current ratio | 5.28 | 7.06 | 16.07 | 17.59 | 13.40 |
| Revenue growth | -41.0% | -53.1% | -99.8% | 695.1% | 37.3% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 116,411 | $2.3M |
| Point72 Asset Management, L.P. | 21,292 | $427,118 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -13.93 (distress)
- Working capital / assets 0.622
- Retained earnings / assets -4.763
- EBIT / assets -0.792
- Equity / liabilities 2.702
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001806952 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.